News

The European Association for the Study of Diabetes (EASD) recently concluded in Vienna, marking an exceptional year of innovation and collaboration in diabetes research. EASD convenes top minds from around the world to set the course for diabetes care. We were proud to showcase our latest findings from the dQ&A team, now available as a downloadable poster.

For over 12 years, dQ&A has gathered primary data from diabetes healthcare practitioners (HCPs)—notably endocrinologists and primary care physicians—expanding our ‘Prescriber Perspectives’ tracker to five countries with insights from key prescribers and influencers.

When it comes to patient-reported outcome measures, getting better or worse is really the bottom line for a disease that sadly tends to get worse over time.

dQ&A data show that users' perceptions of an algorithm's aggressiveness strongly impact satisfaction and NPS.

About 10% of Americans have Type 2 diabetes (T2), often along with obesity and heart disease.

Despite clear evidence that hormonal fluctuations during menstruation impact blood glucose, these effects are often overlooked in diabetes care.

dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.

dQ&A is announcing the availability of new data collected this quarter from ten thousand people with diabetes in the USA, Canada and seven EU countries.